Merck US Versus Merck Germany: Trademark War Heats Up

This article was originally published in The Tan Sheet

25 Jan 2016
News

Vibha Sharma @ScripRegVibha vibha.sharma@informa.com

Executive Summary

US Merck alleges "false advertising, deceptive trade practices, cybersquatting and breach of contract" in complaint that follows German Merck's decision to rebrand itself in the lead up to new CEO Stefan Oschmann taking the top job in April 2016

Already Registered? Sign in to continue reading.

New to Pink Sheet? Start a free trial today!

Table
View full table

Topics

France

Germany

United Kingdom

North America

United States

Related Companies

ASK THE ANALYST
Email

Print
Bookmark
Share

Tags:

BioPharmaceutical Consumer Medical Device

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

PS108133

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

PS108133

All set! This article has been sent to my@email.address.

All fields are required. For multiple recipients, separate email addresses with a semicolon.

Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.

Merck US Versus Merck Germany: Trademark War Heats Up

News

Executive Summary

Topics

Related Companies

You must sign in to use this functionality

Authentication.SignIn.HeadSignInHeader

Register

Ask The Analyst

Email Article

Sign In To Set a Search Alert